Kala’s dry eye syndrome steroid likely to be FDA approved; mixed potential on uptake
To gain FDA approval, DES treatments must demonstrate statistically significant improvements in both signs and symptoms. Credit: liza54500/Shutterstock.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more